Cargando…
Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129125/ https://www.ncbi.nlm.nih.gov/pubmed/37113972 http://dx.doi.org/10.1097/MS9.0000000000000221 |
_version_ | 1785030661846859776 |
---|---|
author | Fareed, Areeba Rohail, Samia Kamran, Ateeba |
author_facet | Fareed, Areeba Rohail, Samia Kamran, Ateeba |
author_sort | Fareed, Areeba |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10129125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101291252023-04-26 Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% Fareed, Areeba Rohail, Samia Kamran, Ateeba Ann Med Surg (Lond) Correspondence, Commentaries and Perspectives Lippincott Williams & Wilkins 2023-03-25 /pmc/articles/PMC10129125/ /pubmed/37113972 http://dx.doi.org/10.1097/MS9.0000000000000221 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Correspondence, Commentaries and Perspectives Fareed, Areeba Rohail, Samia Kamran, Ateeba Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title | Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title_full | Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title_fullStr | Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title_full_unstemmed | Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title_short | Type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
title_sort | type 2 diabetes drug glitazone may help lowering risk of dementia by 22% |
topic | Correspondence, Commentaries and Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129125/ https://www.ncbi.nlm.nih.gov/pubmed/37113972 http://dx.doi.org/10.1097/MS9.0000000000000221 |
work_keys_str_mv | AT fareedareeba type2diabetesdrugglitazonemayhelploweringriskofdementiaby22 AT rohailsamia type2diabetesdrugglitazonemayhelploweringriskofdementiaby22 AT kamranateeba type2diabetesdrugglitazonemayhelploweringriskofdementiaby22 |